Boundless Bio, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -265 | -263 | -247 |
EBITDA | -19,126 | -16,620 | -13,549 |
EBIT | -19,391 | -16,883 | -13,796 |
Net Income | -16,976 | -15,430 | -12,144 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -17,740 | -15,859 | -11,954 |
Cash | 31,363 | 25,143 | 23,706 |
Basic Shares | 22,023 | 22,239 | 22,239 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -957 | -942 | -682 |
EBITDA | -48,477 | -45,527 | -24,619 |
EBIT | -49,434 | -46,469 | -25,301 |
Net Income | -49,434 | -45,901 | -25,210 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -47,488 | -40,662 | -25,282 |
Cash | 23,706 | 10,951 | 34,289 |
Basic Shares | 22,239 | 22,239 | 22,239 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.74 |
2024-06-30 | -$0.77 |
2024-03-31 | -$12.27 |
2019-09-30 | -$1 |
